Clinical Trial Update: A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer [Phase 4]

View source ↗

Summary

Phase 4 web-based study assessing quality of life benefits of Aranesp in anemic cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Anemia, Cancer | Phase 4 | Status: COMPLETED